clinical trial · NCT04679740
Resorbable Magnesium Scaffolds Registry
Biotronik AG·—·recruiting·n = 1,106
Coronary Artery DiseaseMagmarisFreesolve
brief summary
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).
started
Nov 18, 2020
primary completion
May 1, 2030
completion
May 1, 2030
last updated
Nov 21, 2025
official title
RMS (Resorbable Magnesium Scaffolds) Registry
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol